During the evolution of metazoans and the rise of systemic hormonal regulation, the insulin-controlled class 1 phosphatidylinositol 3OH-kinase (PI3K) pathway was merged with the primordial amino acid-driven mammalian target of rapamycin (mTOR) pathway to control the growth and development of the organism. Insulin regulates mTOR function through a recently described canonical signaling pathway, which is initiated by the activation of class 1 PI3K. However, how the amino acid input is integrated with that of the insulin signaling pathway is unclear. Here we used a number of molecular, biochemical, and pharmacological approaches to address this issue. Unexpectedly, we found that a major pathway by which amino acids control mTOR signaling is distinct from that of insulin and that, instead of signaling through components of the insulin͞class 1 PI3K pathway, amino acids mediate mTOR activation by signaling through class 3 PI3K, hVps34.insulin ͉ nutrients ͉ S6 kinase 1 ͉ endosomes ͉ PI3P
Dysfunctional mTORC1 signaling is associated with a number of human pathologies owing to its central role in controlling cell growth, proliferation, and metabolism. Regulation of mTORC1 is achieved by the integration of multiple inputs, including those of mitogens, nutrients, and energy. It is thought that agents that increase the cellular AMP/ATP ratio, such as the anti-diabetic biguanides metformin and phenformin, inhibit mTORC1 through AMPK activation of TSC1/2-dependent or -independent mechanisms. Unexpectedly, we found that biguanides inhibit mTORC1 signaling, not only in the absence of TSC1/2, but also in the absence of AMPK. Consistent with these observations, in two distinct pre-clinical models of cancer and diabetes, metformin acts to suppress mTORC1 signaling in an AMPK-independent manner. We found that the ability of biguanides to inhibit mTORC1 activation and signaling is, instead, dependent on the Rag GTPases.
Insulin resistance is a key mediator of obesity-related cardiometabolic
disease, yet the mechanisms underlying this link remain obscure. Using an
integrative genomic approach, we identify 53 genomic regions associated with
insulin resistance phenotypes (higher fasting insulin adjusted for BMI, lower
HDL cholesterol and higher triglycerides) and provide evidence that their link
with higher cardiometabolic risk is underpinned by an association with
lower adipose mass in peripheral compartments. Using these
53 loci, we show a polygenic contribution to familial partial lipodystrophy-type
1, a severe form of insulin resistance, and highlight shared molecular
mechanisms between common/mild and rare/severe insulin resistance.
Population-level genetic analyses combined with experiments in cellular models
implicate CCDC92, DNAH10 and L3MBTL3 as previously unrecognised molecules
influencing adipocyte differentiation. Our findings support the notion that
limited storage capacity of peripheral adipose tissue is an important
aetiological component in insulin-resistant cardiometabolic disease and
highlight genes and mechanisms underpinning this link.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.